Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Immunitor

2000 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of vaccines. The company i9s engaged in the development and manufacturing of oral vaccines for human immunodeficiency virus, hepatitis B and C, influenza, tuberculosis, and bacterial and fungal infections.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Acquirer
Immune Network
Primary Office
  • Canada

Immunitor Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Immunitor‘s full profile, request access.

Request full access to PitchBook

Immunitor Executive Team (1)

Name Title Board
Seat
Contact
Info
Aldar Bourinbaiar Chief Executive Officer & Principal